Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|December 3, 2013
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trialEvangelos J Giamarellos-Bourboulis, Vassiliki Mylona, Anastasia Antonopoulou, et al.
Frontiers in Immunology|September 19, 2022
Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at riskMaria Tsilika, Esther Taks, Konstantinos Dolianitis, et al.
Frontiers in Immunology|July 22, 2022
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at RiskMaria Tsilika, Esther Taks, Konstantinos Dolianitis, et al.
Journal of Innate Immunity|December 1, 2021
ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 PatientsEleni Karakike, George N Dalekos, Ioannis Koutsodimitropoulos, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortiumAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.
Nature Medicine|October 1, 2025
A consensus immune dysregulation framework for sepsis and critical illnessesAndrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
JAMA|December 8, 2025
Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical TrialEvangelos J Giamarellos-Bourboulis, Antigone Kotsaki, Ioanna Kotsamidi, et al.
Critical Care (London, England)|May 28, 2010
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infectionCharalambos Gogos, Antigone Kotsaki, Aimilia Pelekanou, et al.
Pageof 5